Purchase Order 75N93018P00958
Award Date 7/27/18
Potential Completion Date 10/31/18
Potential Value $101K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The $3,504.92 award is for the provision of sequencing systems, reagents, and related services to support genomic research and diagnostics. Illumina has a history of providing these types of goods and services to federal...
- The U.S. Department of Health and Human Services National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,753.75 firm fixed-price delivery order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The award is not designated as a set-aside contract. Through this order, Illumina will provide biosequencing materials to support NIAID's biomedical research activities. Illumina has previously received prime federal contracts and subcontracts...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $148,811.70 firm fixed price delivery order is for the provision of Illumina consumables. This award is not associated with any set-aside program. Illumina has previously provided sequencing systems, reagents, and services to support genomic...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
- This is a $32,754.46 firm fixed price delivery order contract awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract provides Illumina's sequencing systems, reagents, and associated services to support genomic research and diagnostics. No set-aside was used. Illumina has previously received other prime federal contract and subcontract awards from agencies like the NIH,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $249,229.80 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analytical instruments and reagents. The contract is for the provision of Illumina's sequencing systems, reagents, and associated products and services to support genomic research and diagnostics. This award...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...